Semaphorin-3A Promotes Degradation of Fragile X Mental Retardation Protein in Growth Cones via the Ubiquitin-Proteasome Pathway

• Published in: Frontiers in neural circuits Vol. 14; p. 5
• Main Authors: Takabatake, Masaru, Goshima, Yoshio, Sasaki, Yukio
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Research Foundation 28.02.2020; Frontiers Media S.A
• Subjects: Animal behavior; Axon guidance; Axonal plasticity; Brain-derived neurotrophic factor; Dendritic spines; Experiments; FMR1 protein; fragile X mental retardation protein; Fragile X syndrome; growth cone; Growth cones; Hippocampus; Intellectual disabilities; Localization; Microtubule-associated protein 1; microtubule-associated protein 1B; Morphology; Neural networks; Neurons; Neuroscience; Phosphorylation; Proteasome inhibitors; Proteasomes; Proteins; Ribonucleic acid; RNA; RNA-binding protein; semaphorin; Semaphorins; Synaptic plasticity; Translation; Ubiquitin; Variance analysis; growth cone; semaphorin; proteasome; fragile X syndrome; fragile X mental retardation protein; axon guidance; microtubule-associated protein 1B; ubiquitin
• ISSN: 1662-5110; 1662-5110
• DOI: 10.3389/fncir.2020.00005

Fragile X mental retardation protein (FMRP) is an RNA-binding protein that regulates local translation in dendrites and spines for synaptic plasticity. In axons, FMRP is implicated in axonal extension and axon guidance. We previously demonstrated the involvement of FMRP in growth cone collapse a translation-dependent response to Semaphorin-3A (Sema3A), a repulsive axon guidance factor. In the case of attractive axon guidance factors, RNA-binding proteins such as zipcode binding protein 1 (ZBP1) accumulate towards the stimulated side of growth cones for local translation. However, it remains unclear how Sema3A effects FMRP localization in growth cones. Here, we show that levels of FMRP in growth cones of hippocampal neurons decreased after Sema3A stimulation. This decrease in FMRP was suppressed by the ubiquitin-activating enzyme E1 enzyme inhibitor PYR-41 and proteasome inhibitor MG132, suggesting that the ubiquitin-proteasome pathway is involved in Sema3A-induced FMRP degradation in growth cones. Moreover, the E1 enzyme or proteasome inhibitor suppressed Sema3A-induced increases in microtubule-associated protein 1B (MAP1B) in growth cones, suggesting that the ubiquitin-proteasome pathway promotes local translation of MAP1B, whose translation is mediated by FMRP. These inhibitors also blocked the Sema3A-induced growth cone collapse. Collectively, our results suggest that Sema3A promotes degradation of FMRP in growth cones through the ubiquitin-proteasome pathway, leading to growth cone collapse local translation of MAP1B. These findings reveal a new mechanism of axon guidance regulation: degradation of the translational suppressor FMRP the ubiquitin-proteasome pathway.